VOYA Investment Management
PNT

VOYA Investment Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

VOYA Investment Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,733
Closed -$245K – 2933
2023
Q3 		$245K Buy
36,733
+742
+2% +$6.17K ﹤0.01% 2421
2023
Q2 		$326K Buy
35,991
+3,931
+12% +$34.7K ﹤0.01% 2315
2023
Q1 		$233K Hold
32,060
– – ﹤0.01% 2447
2022
Q4 		$234K Buy
32,060
+2,550
+9% +$18.9K ﹤0.01% 2490
2022
Q3 		$228K Buy
29,510
+1,467
+5% +$12.5K ﹤0.01% 2521
2022
Q2 		$191K Buy
+28,043
New +$215K ﹤0.01% 2414

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VOYA Investment Management's PNT Position: Q4 2023 in Review

VOYA Investment Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 36,733 shares — an estimated $245K sold.

VOYA Investment Management first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $326K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • VOYA Investment Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • VOYA Investment Management sold 36,733 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $245K.
  • VOYA Investment Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • VOYA Investment Management's POINT Biopharma Global Inc. Common Stock position peaked at $326K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on VOYA Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.